Compare Bank of America Corp (BAC) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank of America Corp vs Neurocrine Biosciences Inc — how do they compare? Bank of America Corp trades at $60.8 (market cap $425.43B), while Neurocrine Biosciences Inc trades at $170.05 (market cap $17.30B). The key difference: Bank of America Corp is far larger — about 24.6× Neurocrine Biosciences Inc's market cap, and Bank of America Corp pays a 1.85% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| BAC | NBIX | |
|---|---|---|
Market Cap | $425.43B | $17.30B |
Volume | 55,637,172 | — |
Sector | Financials | Health |
52-Week High | $60.62 | $180.55 |
52-Week Low | $44.92 | $123.10 |
Dividend Yield | 1.85% | — |
Enterprise Value | — | $16.39B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank of America Corp
Bank of America Corporation operates as a financial holding company. The Company offers saving accounts, deposits, mortgage and construction loans, cash and wealth management, certificates of deposit, investment funds, credit and debit cards, insurance, mobile, and online banking services. Bank of America serves customers worldwide.
Read more on BAC →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
